According to Cardiovascular Systems's latest financial reports the company's current revenue (TTM ) is NZ$0.41 Billion. In 2021 the company made a revenue of NZ$0.36 Billion an increase over the revenue in the year 2020 that were of NZ$0.31 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2022 (TTM) | NZ$0.38 B | 3.57% |
2021 | NZ$0.36 B | 16.43% |
2020 | NZ$0.31 B | -19.35% |
2019 | NZ$0.39 B | 13.88% |
2018 | NZ$0.34 B | 18.05% |
2017 | NZ$0.29 B | 4.92% |
2016 | NZ$0.27 B | 5.39% |
2015 | NZ$0.26 B | 28.83% |
2014 | NZ$0.20 B | 43.47% |
2013 | NZ$0.14 B | 26.76% |
2012 | NZ$0.11 B | 9.63% |
2011 | NZ$0.10 B | 11% |
2010 | NZ$92.61 M | 10.09% |
2009 | NZ$84.12 M | |
2006 | NZ$22.69 M | 3417.33% |
2005 | NZ$0.64 M | -44.8% |
2004 | NZ$1.16 M |